Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Details : Lambdalina (Lidocaine) is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Anesthesia, Local.
Product Name : Lambdalina
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 26, 2011